RxDoctor Payments Data

Allen Nimetz

Cardiovascular Disease · Chevy Chase, MDNPI 1003881871

Payments from drug & device makers

$1,407in general payments, 2019–2025

Across 71 payments — averaging $19.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$191
  • Novartis$178
  • Pfizer$148
  • Johnson & Johnson$125
  • Amgen$123
  • Regeneron Healthcare Solutions, Inc.$107
  • plus $534 from 14 others

What the payments were for

  • Food & beverage$1,407100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,407 in reported general payments places this provider in the 45th percentile of 507 cardiovascular disease providers in Maryland.

See all cardiovascular disease providers in Maryland

Other cardiovascular disease in Chevy Chase

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →